Мировой рынок сыворотки – тенденции отрасли и прогноз до 2031 года

Анализ и размер рынка сыворотки

Рынок переживает значительный рост из-за нескольких ключевых факторов. Одним из основных драйверов является растущее использование сыворотки в различных приложениях, включая клеточные культуры, диагностику и биофармацевтическое производство. Растущий спрос на клеточную терапию и регенеративную медицину подпитывает рост рынка, поскольку сыворотка важна для поддержки роста и жизнеспособности клеток. Ожидается, что рынок будет расти, обусловленный достижениями в технологии клеточных культур и растущим внедрением сыворотки в исследования и клинические приложения.

Объем мирового рынка сыворотки в 2023 году оценивался в 1,57 млрд долларов США, а к 2031 году, по прогнозам, он достигнет 3,37 млрд долларов США, при среднегодовом темпе роста в 10% в прогнозируемый период с 2024 по 2031 год. Помимо аналитических данных о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные Data Bridge Market Research, также включают в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ поставок, анализ цен и нормативно-правовую базу.

Область отчета и сегментация рынка       

Market Definition

Serum refers to the clear, yellowish fluid that remains after blood has clotted and the clot has been removed. It is essentially blood plasma without the clotting factors. The serum contains water, electrolytes, antibodies, antigens, hormones, and any exogenous substances (e.g., drugs or microorganisms) in the blood.                      

Serum Market Dynamics

Drivers

• Growing Biopharmaceutical Industry 

The biopharmaceutical industry is witnessing significant growth due to the increasing prevalence of chronic diseases and the demand for personalized medicine. Biopharmaceuticals often require serum in their production processes, driving the demand for serum products. The development of novel therapies, including biologics and biosimilars, further boost the demand for serum. In addition, the rise in healthcare expenditure and investments in research and development are contributing to the expansion of the biopharmaceutical industry, driving market growth.      

• Rising Demand for Cell Culture Technology  

Cell culture technology is crucial in pharmaceutical and biotechnology research, allowing researchers to study cell behavior and develop new therapies. Serum is often employed as a growth supplement in cell culture media to support the growth and proliferation of cells. The increasing adoption of cell culture techniques in drug discovery, regenerative medicine, and vaccine production drives the demand for serum. Moreover, advancements in cell culture technology, such as the development of serum-free media and three-dimensional (3D) cell culture systems, are expanding cell culture applications, further fueling the demand for serum products.        

Opportunities

• Increasing Prevalence of Chronic Diseases

Chronic diseases are rising due to factors such as aging populations, unhealthy lifestyles, and environmental factors. Chronic diseases such as cancer, diabetes, and cardiovascular disorders utilize serum samples for regular monitoring through diagnostic tests. As the prevalence of these diseases continues to increase, the demand for diagnostic tests is also expected to rise, creating a significant market opportunity for serum-based diagnostics and opportunities for the serum market to grow.    

• Growing Research and Development Activities

The life sciences and biotechnology sectors are experiencing rapid growth, driven by technological advancements, increasing funding for research, and a growing focus on personalized medicine. This growth has led to expanding research and development activities in areas such as stem cell research, regenerative medicine, and drug discovery. Serum plays a vital role in numerous research applications, providing a nutrient-rich medium for cell culture and serving as a source of biomarkers for various studies. The growing demand for serum in research and development activities presents a significant market opportunity for serum manufacturers and suppliers. As research advances, the demand for high-quality serum products is expected to remain strong, creating opportunities for market growth.

Restraints/Challenges

• Ethical Concerns Regarding Animal Welfare

Serum is traditionally obtained from animal sources, primarily fetal bovine serum (FBS), which raises ethical concerns regarding animal welfare. The process of collecting serum from fetal bovine blood involves the slaughter of pregnant cows, leading to criticism from animal rights groups and some researchers. To address these concerns, there has been an increasing focus on the development of cell culture media that do not require serum. These alternative media formulations aim to eliminate the need for serum derived from animals, which could potentially limit the growth of the serum market in the future.

• High Cost of Serum

Serum, particularly FBS, is a relatively expensive component of cell culture media. The high cost of serum can be attributed to various factors, including the labor-intensive process of collecting and processing serum and the limited availability of FBS due to strict regulations on its production and export. The high serum cost can pose a barrier to its widespread use, especially in research settings with limited budgets. As a result, researchers and biotechnology companies are exploring alternative media formulations that can achieve similar results at a lower cost, potentially impacting the demand for serum in the market.

This serum market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the serum market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Serum Market Scope

The is segmented on the basis of type, inactivation technique, application, sales channel, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Bovine Serum
• FBS
• Other

 Inactivation Technique

• Heat Inactivated
• Non-Heat Inactivated

 Application

• Biological Products
• Research
• Cell Culture
• Biopharmaceutical Drugs
• Vaccine Products
• Diagnostic Products
• Others

End User

• Biopharmaceutical and Biotechnology Industry
• Diagnostics Laboratories
• Research Laboratories
• Academic Research

 Sales Channel

• Direct Channel
• Distribution Channe

Serum Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, type, inactivation technique, application, sales channel, and end user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

North America is expected to dominate the market due to the region's growing focus on biological product research. The presence of a well-established healthcare infrastructure, high adoption of advanced medical technologies, and significant investments in research and development are also driving market growth.

Asia-Pacific is expected to witness significant growth during the forecast period due to increasing technological advancements and factors such as the rising geriatric population, increasing prevalence of chronic diseases, and improving healthcare infrastructure. Moreover, expanding the biopharmaceutical and life sciences industries in countries such as China, India, and Japan contributes to the region's growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Рынок также предоставляет вам подробный анализ рынка для каждой страны по росту расходов на здравоохранение для капитального оборудования, установленной базы различных видов продуктов для рынка, влияния технологий с использованием кривых жизненной линии и изменений в сценариях регулирования здравоохранения и их влияния на рынок сыворотки. Данные доступны за исторический период 2011-2021 гг.

Анализ конкурентной среды и доли рынка сывороток

Конкурентная среда рынка содержит сведения о конкурентах. Включены сведения о компании, ее финансах, полученном доходе, рыночном потенциале, инвестициях в исследования и разработки, новых рыночных инициативах, глобальном присутствии, производственных площадках и объектах, производственных мощностях, сильных и слабых сторонах компании, запуске продукта, широте и широте продукта, доминировании приложений. Приведенные выше данные касаются только фокуса компаний на рынке.

Некоторые из основных игроков, работающих на рынке:

• Thermo Fisher Scientific Inc (США)
• Merck KGaA (Германия)
• Цитива (США)
• Био-Техне (США)
• Atlas Biologicals, Inc. (США)
• Rocky Mountain Biologicals (США)
• Takara Bio Inc. (Япония)
• PAN-Biotech (Германия)
• Сарториус АГ (Германия)
• Корнинг Инкорпорейтед (США)
• Bovogen Biologicals Pty Ltd. (Австралия)
• Moregate Biotech (Австралия)
• BIOWEST SAS (Франция)
• Caisson Labs Inc. (США)
• Gemini Bio (США)

SKU-56873